A new vaccine covering four meningococcal serogroups has been approved in Russia, highlighting renewed efforts to expand protection against a rapidly progressing infection.
Timely vaccination remains one of the most effective ways to guard against several bacterial infections that can lead to meningitis, according to neurology specialist Ekaterina Demyanovskaya, who said the strongest scientifically supported protection comes from immunisation. She noted that modern medicine relies on vaccines against three major bacterial threats: pneumococcus, meningococcus and Haemophilus influenzae type b, or Hib.
Public health guidance from the US Centres for Disease Control and Prevention says meningococcal vaccines are available in several forms, including MenACWY, MenB and MenABCWY, and are designed to protect against different serogroups of Neisseria meningitidis, the bacterium behind meningococcal disease. The CDC and the American Academy of Family Physicians both stress that routine vaccination reduces the risk of bacterial meningitis and its potentially severe complications. The CDC also says Hib vaccination is a key defence against invasive disease, including meningitis, sepsis and pneumonia.
Demyanovskaya said the vaccines are already part of routine childhood immunisation, reinforcing the view of paediatric and infectious-disease experts that prevention is strongest when protection is built early. The doctor also said the risk is higher in settings where close contact makes transmission easier, including university dormitories, military barracks and international travel.
That message is particularly relevant as Russian health authorities and private developers continue to expand vaccine options. Petrovax Pharm has said Russia’s first domestically produced quadrivalent meningococcal vaccine has been registered for people aged three months to 55 years, with protection against serogroups A, C, W and Y. The company says the aim is to broaden protection against meningococcal infection, which can progress rapidly and has a high fatality rate.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
